Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer
Dongqiang Zeng, Zilan Ye, Jiani Wu, et al.
Theranostics (2020) Vol. 10, Iss. 15, pp. 7002-7014
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
Dongqiang Zeng, Zilan Ye, Rongfang Shen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 753
An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma
Yue Chen, Zhiyong Li, Guan‐Qun Zhou, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 1, pp. 330-341
Open Access | Times Cited: 218
m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer
Wei Chong, Liang Shang, Jin Liu, et al.
Theranostics (2020) Vol. 11, Iss. 5, pp. 2201-2217
Open Access | Times Cited: 177
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
Dongqiang Zeng, Jiani Wu, Hui Luo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002467-e002467
Open Access | Times Cited: 169
Liquid Biopsies, Novel Approaches and Future Directions
Athanasios Armakolas, Maria Kotsari, John Koskinas
Cancers (2023) Vol. 15, Iss. 5, pp. 1579-1579
Open Access | Times Cited: 72
Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer
Guangdi Chu, Xiaoyu Ji, Yonghua Wang, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 110-126
Open Access | Times Cited: 44
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma
Ying Wang, Zhaojie Lyu, Yanru Qin, et al.
Theranostics (2020) Vol. 10, Iss. 25, pp. 11535-11548
Open Access | Times Cited: 121
A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint
Xiaohan Zhou, Jun Du, Chengdong Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 74
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer
Hongyu Zhang, Zilong Liu, Haoyu Wen, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2511-2522
Closed Access | Times Cited: 67
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 24
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
Birgit Fendl, Anna S. Berghoff, Matthias Preusser, et al.
ESMO Open (2023) Vol. 8, Iss. 1, pp. 100776-100776
Open Access | Times Cited: 23
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
Kang Wang, Ioannis Zerdes, Henrik J. Johansson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single‐cell RNA sequencing
Yunfang Yu, Haizhu Chen, Wenhao Ouyang, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 10
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
M.M. Leblond, Hana Zdimerova, Emma Desponds, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4712-4712
Open Access | Times Cited: 52
The N6-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
Rongrong Zhao, Boyan Li, Shouji Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 43
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
Yuru Chen, Jiazheng Sun, Yachan Luo, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33
Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer
Shi Fu, Zhi‐Yong Tan, Hongjin Shi, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 6
CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer
Zongtai Zheng, Yadong Guo, Xiongsheng Huang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4866-4866
Open Access | Times Cited: 28
Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation
Yang Yu, Yuexi Huang, Chen Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 25
Characterization of the metabolic alteration-modulated tumor microenvironment mediated by TP53 mutation and hypoxia
Kunpeng Luo, Zhipeng Qian, Yanan Jiang, et al.
Computers in Biology and Medicine (2023) Vol. 163, pp. 107078-107078
Closed Access | Times Cited: 16
Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy
Jianying Li, Anjun Ma, Ruohan Zhang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 3
Open Access | Times Cited: 6
Update on current and new potential immunotherapies in breast cancer, from bench to bedside
Emmanuelle Alaluf, Michal Mia Shalamov, Amir Sonnenblick
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Identification of crucial genes through WGCNA in the progression of gastric cancer
Rui Liu, Jie Liu, Qiang Cao, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3284-3296
Open Access | Times Cited: 6
M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway
Fan Guo, Weina Kong, Dewei Li, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
Yueqin Sun, Qi Yang, Jie Shen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top